Showing results (11-20 of 369) with videos related to
Sort By:
Pageof 37
Handbook of Experimental Pharmacology|May 26, 2024
Introduction: A Short History of Adrenoceptor ResearchMartin C MichelJournal of Clinical Medicine|July 14, 2023
Progress in Functional Urology Reflected in Recent Papers in the Journal of Clinical MedicineMartin C MichelNeurourology and Urodynamics|November 2, 2022
Are β3 -adrenoceptor gene polymorphisms relevant for urology?Martin C MichelExpert Opinion on Pharmacotherapy|June 24, 2008
Fesoterodine: a novel muscarinic receptor antagonist for the treatment of overactive bladder syndromeMartin C MichelInternational Journal of Urology : Official Journal of the Japanese Urological Association|February 10, 2020
Where will the next generation of medical treatments for overactive bladder syndrome come from?Martin C MichelDrug Safety|September 21, 2002
A benefit-risk assessment of extended-release oxybutyninMartin C MichelEuropean Journal of Pharmacology|October 10, 2020
α1-adrenoceptor activity of β-adrenoceptor ligands - An expected drug property with limited clinical relevanceMartin C MichelHandbook of Experimental Pharmacology|February 4, 2011
β-Adrenergic Receptor Subtypes in the Urinary TractMartin C MichelAnnual Review of Pharmacology and Toxicology|September 25, 2014
Therapeutic modulation of urinary bladder function: multiple targets at multiple levelsMartin C MichelInternational Journal of Molecular Sciences|July 13, 2024
Ligand-Receptor Interactions and Structure-Function Relationships in Off-Target Binding of the β3-Adrenergic Agonist Mirabegron to α1A-Adrenergic ReceptorsRu Huang, Qingfeng Yu, Alexander Tamalunas, et al.Pageof 37